Illexcor Therapeutics

Richmond, United States

Illexcor Therapeutics focuses on discovering and developing new oral treatments for sickle cell disease.

$13.0M raised

May 2026

Venture - Series Unknown

Biotechnology Medical Pharmaceutical

Top Investors

Zynext Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Illexcor Therapeutics

How much funding has Illexcor Therapeutics raised?

Illexcor Therapeutics has raised $13.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2026.

Who are Illexcor Therapeutics's investors?

Illexcor Therapeutics's investors include Zynext Ventures.

Where is Illexcor Therapeutics headquartered?

Illexcor Therapeutics is headquartered in Richmond, United States.

What does Illexcor Therapeutics do?

Illexcor Therapeutics focuses on discovering and developing new oral treatments for sickle cell disease.

What stage is Illexcor Therapeutics at?

Illexcor Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 7, 2026.

MLA

"Illexcor Therapeutics — Funding & Investors." VCBacked, May 7, 2026, https://www.vcbacked.co/company/illexcor-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2026). Illexcor Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/illexcor-therapeutics

Wikipedia (cite web)

{{cite web |title=Illexcor Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/illexcor-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 7, 2026.